- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01964274
Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients (CESARO)
In this prospective, multicenter observational study the investigators capture the perioperative course of peripheral cholinesterase activity. The focus is the perioperative inflammation causing postoperative delirium. Therefore we measure the activity of Acetylcholine-Esterase and Butyrylcholine-Esterase in whole blood of adults in the perioperative context. Early postoperative delirium will be detected by Nu-DESC in the Recovery Room or the Postanaesthesia-Care-Unit. The course of the peripheral cholinesterase activity will be compared with the incidence of postoperative delirium and other clinical dysfunctions.
We follow up the patients for up to five years regarding Delirum, comorbidities and mortality data.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Berlin, Tyskland, 13353
- Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
-
Berlin, Tyskland, 14129
- Department of Anesthesia, Klinik für MIC
-
Bochum, Tyskland, 44789
- Clinic for Anaesthesiology, Intensive Care Medicine, Palliative Medicine and Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil
-
Heidelberg, Tyskland, 69120
- Department of Anesthesiology, Universitätsklinikum Heidelberg
-
München, Tyskland, 81377
- Department of Anesthesiology, Klinikum Großhadern of the Ludwig Maximilians University of Munich
-
Regensburg, Tyskland, 93053
- Department of Anesthesiology, Universitätsklinikum Regensburg
-
Ulm, Tyskland, 89081
- Department of Anesthesiology, Universitätsklinikum Ulm
-
Wetzlar, Tyskland, 35578
- Department of Anesthesiology and Intensive Care Medicine
-
Würzburg, Tyskland, 97080
- Department of Anaesthesia and Critical Care, Universitätsklinikum Würzburg
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Male and female patients with age 18 years and above scheduled for surgery with planned stay in Recovery Room or Postanesthesia-Care-Unit
- Offered patient information and written informed consent
- In-hospital stay for at least 24 hours
Exclusion Criteria:
- Patients with known pseudocholinesterase deficiency
- Participation in prospective intervention studies during the study period
- Analphabetism
- Unability of German and English language use
- Anacusis or Hypoacusis with hearing aid device, Amaurosis
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- Coworker of the clinic (study center)
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Surgical patients
Adult male and female patients undergoing surgery
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Postoperative Delirium
Tidsram: Participants will be followed in the sample period, an exspected average of three days
|
Postoperative Delirium (measured by Nursing Delirium Screening Scale)
|
Participants will be followed in the sample period, an exspected average of three days
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Organ Dysfunctions
Tidsram: Participants will be followed in the sample period, an exspected average of three days
|
Participants will be followed in the sample period, an exspected average of three days
|
|
|
Concomitant medication
Tidsram: Participants will be followed in the three postoperative days sample period
|
Concomitant medications from Anticholinergic Drug Scale (ADS)
|
Participants will be followed in the three postoperative days sample period
|
|
Postoperative Pain
Tidsram: Participants will be followed in the three postoperative days sample period
|
According to Numeric Rating Scale
|
Participants will be followed in the three postoperative days sample period
|
|
Duration of Intensive Care Unit Stay
Tidsram: Participants will be followed in the sample period, an exspected average of seven days
|
Participants will be followed in the sample period, an exspected average of seven days
|
|
|
Duration of Hospital Stay
Tidsram: Participants will be followed in the sample period, an exspected average of four weeks
|
Participants will be followed in the sample period, an exspected average of four weeks
|
|
|
Duration of Mechanical Ventilation
Tidsram: Participants will be followed in the sample period, an exspected average of 168 hours
|
Participants will be followed in the sample period, an exspected average of 168 hours
|
|
|
Readmission rate
Tidsram: Participants will be followed in the sample period, an exspected average of four weeks
|
Participants will be followed in the sample period, an exspected average of four weeks
|
|
|
Hospital Treatment Data
Tidsram: Participations will be followed for the duration of the operation day, an exspected time average of eight hours
|
Operation time, surgery, anaesthesia
|
Participations will be followed for the duration of the operation day, an exspected time average of eight hours
|
|
Postoperative Mortality
Tidsram: Participants will be followed for the duration of the sample period an exspected average of five years
|
Mortality (measured inhouse-mortality according to the patients´records and based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG))
|
Participants will be followed for the duration of the sample period an exspected average of five years
|
|
Postoperative Delirium
Tidsram: Participants will be followed in the sample period, an exspected average of five years
|
Postoperative Delirium (measured by Diagnosis of Delirium according to the patients´records and based on the data record according to §21 Krankenhausentgeltgesetz -(KHEntgG))
|
Participants will be followed in the sample period, an exspected average of five years
|
|
Comorbidities
Tidsram: Participants will be followed in the sample period, an exspected average of five years
|
Comorbidities based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG)
|
Participants will be followed in the sample period, an exspected average of five years
|
Samarbetspartners och utredare
Utredare
- Studierektor: Claudia Spies, MD, Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
Publikationer och användbara länkar
Allmänna publikationer
- Muller A, Olbert M, Heymann A, Zahn PK, Plaschke K, von Dossow V, Bitzinger D, Barth E, Meister M, Kranke P, Herrmann C, Wernecke KD, Spies CD. Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): A prospective observational cohort study. Eur J Anaesthesiol. 2019 Feb;36(2):114-122. doi: 10.1097/EJA.0000000000000888.
- Michels B, Holzamer A, Graf BM, Bredthauer A, Petermichl W, Muller A, Zausig YA, Bitzinger DI. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021 Jul 6;11(7):e042857. doi: 10.1136/bmjopen-2020-042857.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CESARO
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .